Antiphospholipid Antibodies From Antiphospholipid Syndrome Patients Activate Endothelial Cells In Vitro and In Vivo
- 20 April 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (15) , 1997-2002
- https://doi.org/10.1161/01.cir.99.15.1997
Abstract
Background—Antiphospholipid (aPL) antibodies are associated with thrombosis in patients diagnosed with antiphospholipid syndrome (APS) and enhance thrombus formation in vivo in mice, but the mechan...Keywords
This publication has 35 references indexed in Scilit:
- Do leukocytes contribute to impaired microvascular tissue perfusion after arterial repair?Microsurgery, 1998
- Thrombogenic properties of antiphospholipid antibodies do not depend on their binding to β2 glycoprotein 1 (β2GP1) aloneLupus, 1998
- Immunological and Molecular Analysis of Three Monoclonal Lupus Anticoagulant Antibodies from a Patient with Systemic Lupus ErythematosusJournal of Autoimmunity, 1998
- Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosusLupus, 1996
- Are immunoglobulins with lupus anticoagulant activity specific for phospholipids?British Journal of Haematology, 1993
- Detection of endothelial cell‐reactive immunoglobulin in patients with anti‐phospholipid antibodiesBritish Journal of Haematology, 1991
- The “Primary” Antiphospholipid SyndromeMedicine, 1989
- SYNDROME OF THE BLACK SWANRheumatology, 1987
- Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.The Journal of Experimental Medicine, 1986
- A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural PatternsBritish Journal of Haematology, 1978